Health NewsUS Regulators Authorize COVID-19 Vaccine Booster Doses for 16- and 17-Year-OldsSavePrintA health worker draws a dose of Pfizer-BioNTech COVID-19 vaccine in Miami, Fla., on Aug. 5, 2021. Marco Bello/ReutersZachary StieberSenior Reporter12/9/2021|Updated: 12/9/2021U.S. drug regulators on Thursday authorized booster doses of Pfizer’s COVID-19 vaccine for 16- and 17-year-olds.The Food and Drug Administration (FDA) cited in its announcement data showing the vaccine becomes significantly less effective over time.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.Share this articleLeave a commentZachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected Articles7 Deaths of Children Possibly or Probably From COVID-19 Vaccination: FDAJun 20, 2026RFK Jr. Denies CDC Is Spending $1.2 Billion on COVID-19 VaccinesJun 19, 2026Flu Outbreak Sidelines Trainees at Air Force BaseJun 19, 2026Ebola Outbreak Death Toll Tops 200Jun 19, 2026Related TopicsFDAPfizer
